PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1975 February; 68(2): 102–104.
PMCID: PMC1863629

The value of serum diphenylhydantoin (phenytoin) levels in the management of epilepsy.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (540K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Bochner F, Hooper WD, Tyrer JH, Eadie MJ. Effect of dosage increments on blood phenytoin concentrations. J Neurol Neurosurg Psychiatry. 1972 Dec;35(6):873–876. [PMC free article] [PubMed]
  • Booker HE, Darcey B. Serum concentrations of free diphenylhydantoin and their relationship to clinical intoxication. Epilepsia. 1973 Jun;14(2):177–184. [PubMed]
  • Borofsky LG, Louis S, Kutt H, Roginsky M. Diphenylhydantoin: efficacy, toxicity, and dose-serum level relationships in children. J Pediatr. 1972 Nov;81(5):995–1002. [PubMed]
  • Buchanan RA, Allen RJ. Diphenylhydantoin (Dilatin) and phenobarbital blood levels in epileptic children. Neurology. 1971 Aug;21(8):866–871. [PubMed]
  • BUCHTHAL F, SVENSMARK O, SCHILLER PJ. Clinical and electroencephalographic correlations with serum levels of diphenylhydanotin. Arch Neurol. 1960 Jun;2:624–630. [PubMed]
  • Gibberd FB, Dunne JF, Handley AJ, Hazleman BL. Supervision of epileptic patients taking phenytoin. Br Med J. 1970 Jan 17;1(5689):147–149. [PMC free article] [PubMed]
  • Haerer AF, Buchanan RA. Effectiveness of single daily doses of diphenylhydantoin. Neurology. 1972 Oct;22(10):1021–1025. [PubMed]
  • KUTT H, WINTERS W, KOKENGE R, MCDOWELL F. DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY. Arch Neurol. 1964 Dec;11:642–648. [PubMed]
  • KUTT H, WINTERS W, SCHERMAN R, MCDOWELL F. DIPHENYLHYDANTOIN AND PHENOBARBITAL TOXICITY. THE ROLE OF LIVER DISEASE. Arch Neurol. 1964 Dec;11:649–656. [PubMed]
  • KUTT H, WOLK M, SCHERMAN R, MCDOWELL F. INSUFFICIENT PARAPHYDROXYLATION AS A CAUSE OF DIPHENYLHYDANTOIN TOXICITY. Neurology. 1964 Jun;14:542–548. [PubMed]
  • Lascelles PT, Kocen RS, Reynolds EH. The distribution of plasma phenytoin levels in epileptic patients. J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):501–505. [PMC free article] [PubMed]
  • Letteri JM, Mellk H, Louis S, Kutt H, Durante P, Glazko A. Diphenylhydantoin metabolism in uremia. N Engl J Med. 1971 Sep 16;285(12):648–652. [PubMed]
  • LOESER EW., Jr Studies on the metabolism of diphenylhydantoin (Dilantin). Neurology. 1961 May;11:424–429. [PubMed]
  • LUND M, JORGENSEN RS, KUEHL V. SERUM DIPHENYLHYDANTOIN (PHENYTOIN) IN AMBULANT PATIENTS WITH EPILEPSY. Epilepsia. 1964 Mar;5:51–58. [PubMed]
  • Reidenberg MM, Odar-Cederlöf I, von Bahr C, Borgå O, Sjöqvist F. Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function. N Engl J Med. 1971 Jul 29;285(5):264–267. [PubMed]
  • Reynolds EH. Iatrogenic disorders in epilepsy. Mod Trends Neurol. 1970;5(0):271–286. [PubMed]
  • Reynolds EH, Mattson RH, Gallagher BB. Relationships between serum and cerebrospinal fluid anticonvulsant drug and folic acid concentrations in epileptic patients. Neurology. 1972 Aug;22(8):841–844. [PubMed]
  • Reynolds EH, Travers RD. Serum anticonvulsant concentrations in epileptic patients with mental symptoms. A preliminary report. Br J Psychiatry. 1974 May;124(0):440–445. [PubMed]
  • Sherwin AL, Wisen AA, Sokolowski CD. Anticonvulsant drugs in human epileptogenic brain. Correlation of phenobarbital and diphenylhydantoin levels with plasma. Arch Neurol. 1973 Aug;29(2):73–77. [PubMed]
  • Sherwin AL, Robb JP, Lechter M. Improved control of epilepsy by monitoring plasma ethosuximide. Arch Neurol. 1973 Mar;28(3):178–181. [PubMed]
  • Strandjord RE, Johannessen SI. One daily dose of diphenylhydantoin (DPH) to patients with epilepsy. Acta Neurol Scand Suppl. 1972;51:499–500. [PubMed]
  • SVENSMARK O, BUCHTHAL F. DOSAGE OF PHENYTOIN AND PHENOBARBITAL IN CHILDREN. Dan Med Bull. 1963 Dec;10:234–235. [PubMed]
  • SVENSMARK O, SCHILLER PJ, BUCHTHAL F. 5, 5-Diphenylhydantoin (dilantin) blood levels after oral or intravenous dosage in man. Acta Pharmacol Toxicol (Copenh) 1960;16:331–346. [PubMed]
  • Travers RD, Reynolds EH, Gallagher BB. Variation in response to anticonvulsants in a group of epileptic patients. Arch Neurol. 1972 Jul;27(1):29–33. [PubMed]
  • TRIEDMAN HM, FISHMAN RA, YAHR MD. Determination of plasma and cerebrospinal fluid levels of dilantin in the human. Trans Am Neurol Assoc. 1960;85:166–170. [PubMed]
  • Vajda F, Williams FM, Davidson S, Falconer MA, Breckenridge A. Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther. 1974 Jun;15(6):597–603. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press